News

Get to know what's happening behind the scenes.

Learn more

Featured

Blog

Read the latest on our blog. Let's Talk Innovation.

Social

Stay connected with us on social media.

twitter_logo_20px.jpg @JNJinnovation

Events

Pages

Press Releases

Read our latest news.

  • Johnson & Johnson Innovation Announces New Collaboration with Texas Medical Center to Spur Development of Breakthrough Medical Device Technologies

    Houston
    Octobre 18, 2016

    Medical Device Entrepreneur Billy Cohn, M.D. to Lead Johnson & Johnson Innovation's new Center for Device Innovation.

    Johnson & Johnson Innovation LLC (JJI) today announced the creation of the Center for Device Innovation at Texas Medical Center (CDI @ TMC), a broad, new collaboration between JJI and TMC that aims to accelerate end-to-end development of breakthrough medical devices. This expands on JJI's collaboration with TMC established earlier this year with the opening of JLABS @ TMC, combining the resources of the world's largest medical complex with the capabilities of the Johnson & Johnson Medical Devices Companies*, to advance the health and well-being of people around the globe...

  • Johnson & Johnson Innovation Launches a New Company Incubation Model Located at the Janssen Research & Development Campus in Beerse, Belgium

    Beerse, Belgium
    March 16, 2016

    Johnson & Johnson Innovation Launches a New Company Incubation Model Located at the Janssen Research & Development Campus in Beerse, Belgium

  • Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. Announce Agreement with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. to ...

    New Brunswick, N.J.
    January 7, 2016

    Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. today announced an exclusive license agreement with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ), a Chinese domestic pharmaceutical company and subsidiary of Sino Biopharma, Ltd. focused on liver diseases, to develop, manufacture and commercialize, outside of China, undisclosed immune-modulating agents to treat human diseases, including curative treatment of chronic Hepatitis B virus (HBV) infection.

Pages

Accelerators

Close
Neomed (Montreal)
7171 Frederick-Banting
Montreal, Quebec, CANADA H4S 1Z9
(514) 367 1212
mail@www.neomed.ca
www.neomed.ca
Your web browser is out of date. For the most optimal experience, please upgrade to the newest version of IE. Thank You.